article thumbnail

Ada Health : beyond symptom checking to the holy grail of healthcare

Lloyd Price

There’s a lot of hype,” Novorol says; a whole lot more than when she began building an AI-focused business back in 2011. As a result, more and more investors are paying attention to the health sector which, due to its complexity, has traditionally been left to biotech or medical devices investors. And that’s a double-edged sword.

BioTech 52